# Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF)

> Source: Nexqual · https://nexqual.com/RCDTF · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF), nexqual.com/RCDTF" · informational, not investment advice.

**Price:** USD 58.79 (+0.00% on the day) · last close of Oct 22, 2026; US market closed, not a live price. Prev close 58.79 · day 58–58 · 52w 55.88–65.44 · market cap $12.2B · PNK

## Key facts
- Analysts: None.
- Total return with dividends: 1Y -8.1% vs S&P 500 +14.4%; 5Y +9.7% vs S&P 500 +77.0%.
- Next earnings: 2026-11-10, EPS estimate USD —, revenue estimate $674M.

## Analysts
Consensus None.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | -8.1% | +9.7% |
| S&P 500 (SPY) | +14.4% | +77.0% |
| Per year | -8.2% | +1.9% |
| Volatility (annualized) | 15.6% | 26.9% |
| Max drawdown | -14.6% (Nov 2025→Apr 2026) | -42.9% (Nov 2021→Sep 2022) |

## Peers (Drug Manufacturers - General)
GRFS (Grifols, S.A.) USD 7.54 +1.14% · BIIB (Biogen Inc.) USD 250.38 -1.36% · OGN (Organon & Co.) USD 13.76 +0.04% · SNY (Sanofi) USD 41.51 -1.08% · GSK (GSK plc) USD 50.61 -1.17% · BMY (Bristol-Myers Squibb Company) USD 61.53 -2.34%

## More
Full page: https://nexqual.com/RCDTF · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | — | — | — | $674.4M | — |
| Next quarter (ends 2026-12-31) | — | — | — | $684.8M | — |
| Current fiscal year (ends 2026-12-31) | — | — | — | $2.79B | — |
| Next fiscal year (ends 2027-12-31) | — | — | — | $3.03B | — |